Preview

Systemic Hypertension

Advanced search

Efficacy and safety of different regimens of fixed combinationof perindopril 10 mg/indapamide 2.5 mg in patients with arterial hypertension

Abstract

Objective: The most common strategy to improve blood pressure (BP) control is improving compliance with once daily administration of antihypertensive therapy. Aim: To assess the efficacy, tolerability, safety of different regimes of prescription of combination of perindopril 10 mg and indapamide 2.5 mg.Design and methods. We included 31 patients (56±9.3 years, BMI 30.5±5.3 kg/m2, duration of arterial hypertension - 7.1±5.8 years), on two-component therapy (except combination of perindopril and indapamide) with BP>140/90 mmHg. At baseline ambulatory blood pressure monitoring (ABPM), blood tests were performed in 20 men and 10 women, then, patients were randomized into two groups: morning and evening regimes. Previous therapy was canceled and prescribed a combination of perindopril 10 mg and indapamide 2.5 mg. After 8 weeks of treatment, ABPM and blood tests were re-conducted. Results. Baseline systolic blood pressure (SBP) and diastolic blood pressure (DBP) in the whole group - 148.4±10.0/95.6±10.7 mm Hg. After 1 and 2 months of treatment Noliprel-A bi-forte SBP/DBP decreased to 131.4±8.4/86.6±5.7 mm Hg and to 133.4±11.2/84.5±8.8 mm Hg respectively. ( p <0.001 vs baseline). No additional antihypertensive drugs were added. The combination of perindopril 10 mg and indapamide 2.5 mg effectively reduces BP by ABPM data. There was no difference in terms of BP in morning and evening regime groups. Statistically significant changes in blood indices were not detected. Tolerability was assessed by The combination of perindopril 10 mg and indapamide 2.5 mg effectively reduces BP by ABPM data. There was no difference in terms of BP in morning and evening regime groups. Statistically significant changes in blood indices were not detected. Tolerability was assessed by patients as good to very good.Conclusion. The combination of 10 mg perindopril and indapamide 2.5 mg is effective in achieving and maintaining a "target" BP levels. The dosing regimen does not affect the efficacy and tolerability and does not cause additional adverse effects when administered in the evening.

About the Authors

E. M. Elfimova
A.L.Myasnikov Institute of Clinical Cardiology, Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Russian Federation


A. V. Aksenova
A.L.Myasnikov Institute of Clinical Cardiology, Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Russian Federation


A. Yu. Litvin
A.L.Myasnikov Institute of Clinical Cardiology, Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Russian Federation


I. E. Chazova
A.L.Myasnikov Institute of Clinical Cardiology, Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Russian Federation


References

1. Chobanian A.V, Bakris G.L, Black H.R et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42 (6): 1206-52.

2. Ogedegbe G, Harrison M, Robbins L et al. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ethn Dis 2004; 14: 3-12.

3. Clement D.L, De Buyzere M.L, De Bacquer D.A et al. Prognostic value of ambulatory blood - pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407-15.

4. Ben-Dov I.Z, Kark J.D, Ben-Ishay D et al. Predictors of all - cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension 2007; 49: 1235-41.

5. Fagard R.H, Celis H, Thijs L et al. Daytime and nighttime blood pressure as predictors of death and cause - specific cardiovascular events in hypertension. Hypertension 2008; 51: 55-61.

6. Carter B.L. Optimizing delivery systems to tailor pharmacotherapy to cardiovascular circadian events. Am J Health Syst Pharm 1998; 55 (Suppl. 3): 17-23.

7. Smolensky M.H, Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens 2001; 2: 280S-290S.

8. Zhao P, Xu P, Wan C, Wang Z. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database Syst Rev 2011; 10: CD004184.

9. Чазова И.Е. Комбинированная терапия артериальной гипертонии. В кн.: Руководство по артериальной гипертензии. Под ред. Е.И.Чазова, И.Е.Чазовой. М.: Медиа Медика, 2005; с. 655-76.

10. Диагностика и лечение артериальной гипертензии. Российские рекомендации (четвертый пересмотр). Системные гипертензии. 2010; 3.


Review

For citations:


Elfimova E.M., Aksenova A.V., Litvin A.Yu., Chazova I.E. Efficacy and safety of different regimens of fixed combinationof perindopril 10 mg/indapamide 2.5 mg in patients with arterial hypertension. Systemic Hypertension. 2015;12(2):33-37. (In Russ.)

Views: 142


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)